LEHI — A Utah-based diagnostic testing company says its continuing its pursuit of authorization from the U.S. Food and Drug Administration to issue emergency approval for a COVID-19 test that’s already in use in Europe and could markedly amp up testing capacity in Utah and other areas of the Intermountain West.
The company says it has the resources to produce 50,000 or more of the tests daily from its Salt Lake City facility. Each test, according to the company, costs about $10 per patient, delivers results in about 90 minutes and can be processed at most medical labs.
During a community leaders call hosted Monday by Utah tech sector advocacy group Silicon Slopes, Co-Diagnostics communication director Seth Egan said his company has already earned approval from the European Union for its test, which uses a sputum sample to look for evidence of COVID-19, but continues to await action from the FDA under the agency’s expedited emergency use protocol for COVID-19 testing.
Continue Reading on Deseret News